-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
GeneDx Holdings Corp. quarterly/annual Nonoperating Income (Expense) history and change rate from 2019 to Q3 2025.
- GeneDx Holdings Corp. Nonoperating Income (Expense) for the quarter ending September 30, 2025 was -$4.14M, a 615% decline year-over-year.
- GeneDx Holdings Corp. Nonoperating Income (Expense) for the twelve months ending September 30, 2025 was -$7.46M, a 71.9% increase year-over-year.
- GeneDx Holdings Corp. annual Nonoperating Income (Expense) for 2024 was -$29.4M, a 854% decline from 2023.
- GeneDx Holdings Corp. annual Nonoperating Income (Expense) for 2023 was $3.9M, a 94.4% decline from 2022.
- GeneDx Holdings Corp. annual Nonoperating Income (Expense) for 2022 was $69.6M, a 65.3% decline from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)